fimmu.2017.00608

TOP2A Antibody (SWT3D1) Summary

    Immunogen
    Synthetic peptide, corresponding to amino acids 854-1447 of Human Topoisomerase II alpha.
    Localization
    Nuclear
    Specificity
    This is specific to alpha form of DNA topoisomerase II. It stains the nuclei of immunoreactive cells. This is useful in the staining of small cell lung cancer, non-small cell lung carcinoma and breast carcinoma.
    Isotype
    IgG1 Kappa
    Clonality
    Monoclonal
    Host
    Mouse
    Gene
    TOP2A
    Purity
    Tissue culture supernatant
    Innovators Reward
    Test in a species/application not listed above to receive a full credit towards a future purchase.

    Learn about the Innovators Reward

Applications/Dilutions

    Dilutions
        Immunohistochemistry 1:10-1:500
        Immunohistochemistry-Paraffin 1:15-1:35
    Application Notes
    IHC-P: Perform heat mediated antigen retrieval before commencing with IHC staining protocol. An incubation period of 60 minutes at room temperature is suggested, but optimal incubation should be determined by the user.

Reactivity Notes

Human.

Packaging, Storage & Formulations

    Storage
    Store at 4C. Do not freeze.
    Buffer
    No buffer
    Preservative
    Sodium Azide
    Purity
    Tissue culture supernatant

Alternate Names for TOP2A Antibody (SWT3D1)

      DNA topoisomerase (ATP-hydrolyzing)
      DNA topoisomerase 2-alpha
      DNA topoisomerase II, 170 kD
      DNA topoisomerase II, alpha isozyme
      EC 5.99.1.3
      TOP2
      TOP2A
      TOP2DNA gyrase
      topoisomerase (DNA) II alpha (170kD)
      topoisomerase (DNA) II alpha 170kDa
      TP2A

Background

Topoisomerase II alpha plays important roles in synthesis and transcription of DNA as well as chromosomal segregation during mitosis. It is reported to be a sensitive and specific marker of late S, G2 & M phases in transformed and developmentally regulated normal cells. Note that Ki67 / M1B1 is also present in G1 phase. Topoisomerase II alpha is also implicated in drug resistance of tumor cells.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Baricitinib

Related Post